Compare PGIM India Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹1000
₹100
Expense Ratio
2.47
2.85
NAV
₹10.19
₹39.76
Fund Started
19 Nov 2024
25 Jun 2018
Fund Size
₹85.19 Cr
₹6293.14 Cr
Exit Load
Exit load of 0.50%, if redeemed within 90 days.
Exit load of 1% if redeemed within 15 days.
1 Year
7.22%
7.16%
3 Year
-
27.21%
5 Year
-
16.24%
Equity
97.20%
97.62%
Cash
-0.76%
2.35%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 12.41% |
Divi's Laboratories Ltd. | 10.01% |
Aster DM Healthcare Ltd. | 7.51% |
JB Chemicals & Pharmaceuticals Ltd. | 6.98% |
Max Healthcare Institute Ltd. | 5.56% |
Rubicon Research Ltd. | 5.44% |
Ajanta Pharma Ltd. | 5.02% |
Mankind Pharma Ltd. | 4.96% |
Dr. Reddy's Laboratories Ltd. | 3.95% |
Krishna Institute of Medical Sciences Ltd | 3.81% |
Sun Pharmaceutical Industries Ltd. | 12.11% |
Cipla Ltd. | 9.23% |
Mankind Pharma Ltd. | 7.01% |
Biocon Ltd. | 6.08% |
Dr. Reddy's Laboratories Ltd. | 5.97% |
Divi's Laboratories Ltd. | 5.91% |
Lupin Ltd. | 4.09% |
Alkem Laboratories Ltd. | 3.52% |
Syngene International Ltd. | 3.52% |
Aurobindo Pharma Ltd. | 3.30% |
Name
-
-
Start Date
-
-
Description
The scheme seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
19 Nov 2024
25 Jun 2018
